320 related articles for article (PubMed ID: 27658388)
21. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
22. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
Lim MC; Won YJ; Ko MJ; Kim M; Shim SH; Suh DH; Kim JW
J Gynecol Oncol; 2019 Jan; 30(1):e38. PubMed ID: 30574686
[TBL] [Abstract][Full Text] [Related]
23. Trends of human papillomavirus-related head and neck cancers in Korea: national cancer registry data.
Shin A; Jung YS; Jung KW; Kim K; Ryu J; Won YJ
Laryngoscope; 2013 Nov; 123(11):E30-7. PubMed ID: 23754527
[TBL] [Abstract][Full Text] [Related]
24. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016.
Jung KW; Won YJ; Kong HJ; Lee ES
Cancer Res Treat; 2019 Apr; 51(2):417-430. PubMed ID: 30913865
[TBL] [Abstract][Full Text] [Related]
25. Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005.
Akbari ME; Hosseini SJ; Rezaee A; Hosseini MM; Rezaee I; Sheikhvatan M
Asian Pac J Cancer Prev; 2008; 9(4):549-52. PubMed ID: 19256736
[TBL] [Abstract][Full Text] [Related]
26. Trends in incidence and survival of childhood cancers in Khon Kaen, Thailand (2000-2019): a population-based Khon Kaen Cancer Registry study.
Pinsuwan C; Santong C; Chainansamit SO; Komvilaisak P; Sirikarn P; Phimha S; Suwannaying K
BMC Public Health; 2024 May; 24(1):1255. PubMed ID: 38714963
[TBL] [Abstract][Full Text] [Related]
27. Familial risk of urological cancers: data for clinical counseling.
Hemminki K; Li X; Czene K
World J Urol; 2004 Feb; 21(6):377-81. PubMed ID: 14615900
[TBL] [Abstract][Full Text] [Related]
28. The effect of primary urological cancers on survival in men with secondary prostate cancer.
Wenzel M; Würnschimmel C; Nocera L; Ruvolo CC; Tian Z; Saad F; Briganti A; Tilki D; Graefen M; Roos FC; Mandel P; Chun FKH; Karakiewicz PI
Prostate; 2021 Nov; 81(15):1149-1158. PubMed ID: 34402086
[TBL] [Abstract][Full Text] [Related]
29. Lung Cancer Epidemiology in Korea.
Shin A; Oh CM; Kim BW; Woo H; Won YJ; Lee JS
Cancer Res Treat; 2017 Jul; 49(3):616-626. PubMed ID: 27669705
[TBL] [Abstract][Full Text] [Related]
30. Trends in the incidence of and survival rates for oral cavity cancer in the Korean population.
Choi SW; Moon EK; Park JY; Jung KW; Oh CM; Kong HJ; Won YJ
Oral Dis; 2014 Nov; 20(8):773-9. PubMed ID: 24735459
[TBL] [Abstract][Full Text] [Related]
31. Gout patients have an increased risk of developing most cancers, especially urological cancers.
Chen CJ; Yen JH; Chang SJ
Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
[TBL] [Abstract][Full Text] [Related]
32. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
33. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract][Full Text] [Related]
34. Cancer incidence and survival among adolescents and young adults in Korea.
Moon EK; Park HJ; Oh CM; Jung KW; Shin HY; Park BK; Won YJ
PLoS One; 2014; 9(5):e96088. PubMed ID: 24789075
[TBL] [Abstract][Full Text] [Related]
35. [Urologic cancer mortality in France].
Rezvani A
Ann Urol (Paris); 1992; 26(5):266-74. PubMed ID: 1485795
[TBL] [Abstract][Full Text] [Related]
36. [Urologic cancer at the Hérault department: 14 years of continuous registration].
Tretarre B; Rebillard X; Daures JP; Iborra F; Arcou ; Crisap-Lr
Prog Urol; 2003 Jun; 13(3):394-403. PubMed ID: 12940191
[TBL] [Abstract][Full Text] [Related]
37. Is there evidence for a multidisciplinary follow-up after urological cancer? An evaluation of subsequent cancers.
Mathers MJ; Zumbe J; Wyler S; Roth S; Gerken M; Hofstädter F; Klotz T
World J Urol; 2008 Jun; 26(3):251-6. PubMed ID: 18421461
[TBL] [Abstract][Full Text] [Related]
38. National and subnational mortality of urological cancers in Iran, 1990-2015.
Pishgar F; Amini E; Gohari K; Aminorroaya A; Sheidaei A; Rostamabadi Y; Ebrahimi H; Yoosefi M; Naderimagham S; Rezaei N; Modirian M; Namazi Shabestari A; Kompani F; Farzadfar F
Asia Pac J Clin Oncol; 2019 Apr; 15(2):e43-e48. PubMed ID: 30270510
[TBL] [Abstract][Full Text] [Related]
39. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.
Jung KW; Won YJ; Kong HJ; Lee ES;
Cancer Res Treat; 2018 Apr; 50(2):303-316. PubMed ID: 29566481
[TBL] [Abstract][Full Text] [Related]
40. Incidence and survival of adult cancer patients in Taiwan, 2002-2012.
Chiang CJ; Lo WC; Yang YW; You SL; Chen CJ; Lai MS
J Formos Med Assoc; 2016 Dec; 115(12):1076-1088. PubMed ID: 26786251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
